Karuna
is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of mental illnesses... Read moreKaruna
is a Massachusetts-based clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of mental illnesses... Read more
News
Apr 06, 2024
Endpoints News
Karuna: Bristol Myers touts long-term efficacy of recently acquired Karuna drug
Mar 22, 2024
The Business Journals
Karuna: PureTech's newest biotech spinout represents a shift from the past
Mar 21, 2024
Indian Pharma Post
Karuna: Bristol Myers Squibb completes acquisition of Karuna Therapeutics
Mar 20, 2024
The Business Journals
Karuna: PureTech made millions on Karuna acquisition. Here's what it plans to return to shareholders.
Mar 19, 2024
MarketScreener
Karuna: Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from S&P Global BMI Index
Mar 18, 2024
MarketScreener
Karuna: KARA THER : Acquisition/Asset Disposal - Form 8-K
Feb 23, 2024
Zacks
Karuna: Karuna's (KRTX) Q4 Loss Widens, Focus on Bristol Myers Buyout
Feb 22, 2024
Citybizlist
Karuna: Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update
Feb 22, 2024
Benzinga
Karuna: Karuna Therapeutics: Q4 Earnings Insights
Feb 16, 2024
PharmaLive
Karuna: Karuna CEO, board sued by shareholder over $14B BMS acquisition
Karuna Competitors
1
2
3
4
5
6
7
8
9
10